UnknownNot Applicable

Effect of Low-dose Esketamine Combined With Target-controlled Infusion of Propofol for Painless Gastrointestinal Endoscopy

China1,000 participantsStarted 2020-12-01

Plain-language summary

Purpose: 1. To determine the efficacy of low-dose esketamine in painless gastrointestinal endoscopy. 2. To determine the safety of low-dose esketamine in painless gastrointestinal endoscopy. 3. To provide a theoretical basis and new ideas for the application of esketamine as a new drug in perioperative period.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Subject's American Society of Anesthesiologists physical status is I-III.
✓. Subject has no symptoms of allergy to anesthetics.
✓. Subject has no contraindications for gastrointestinal endoscopy.
✓. Subject has given written informed consent to participate.

Exclusion criteria

✕. Subject's BMI \<18 or \>30
✕. Subject has poorly controlled or untreated hypertension.
✕. Subject has severe ischemic heart disease.
✕. Subject is an untreated or undertreated patient with hyperthyroidism.
✕. Subject has used drugs that affect their central nervous system.
✕. .Subject has mental illness.
✕. .Subject has epilepsy.
✕. .Subject has a history of chronic pain.

What they're measuring

Cumulative propofol Consumption

Timeframe: intraoperative

Trial details

NCT IDNCT04691076

SponsorTianjin Union Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-12-01

Contact for this trial

Tao Yang, Master

18920802290 yangtao@nankai.edu.cn

View on ClinicalTrials.gov More Pain trials